Artículos -

Navegar

Últimos Documentos Autor FCEN - Año Autor FCEN - Revista Año - Revista Revista - Año SubjectPcEn Colores Type

Colección

Lista de

$
0
1
-
1
1
-
1
-
1
-
1
1
1
2
3
4
5
6
7
8
9
a
a
-
a
-
a
-
a
-
a
-
a
-
a
-
a
-
a
-
a
-
a
-
‐
a
-
‐
-
a
-
a
-
a
-
a
-
a
-
a
-
‐
a
-
a
-
a
-
a
b
-
b
-
b
-
b
c
-
c
-
c
-
c
-
c
-
c
-
c
-
c
-
c
+
c
-
c
-
c
-
c
-
c
-
c
-
c
-
c
c
-
c
-
c
d
-
d
-
d
-
d
-
d
-
d
-
d
e
-
e
-
e
-
e
-
e
-
e
-
e
-
e
-
e
f
-
f
-
f
f
g
-
g
-
g
-
g
-
g
-
g
-
g
-
g
-
‐
g
-
g
-
‐
g
-
g
h
‐
h
h
-
h
-
h
-
h
-
h
i
-
i
j
k
-
k
-
k
-
k
-
k
-
k
l
-
l
-
l
-
l
-
l
-
l
-
l
l
+
l
±
l
l
m
-
m
-
m
-
m
-
m
-
m
+
m
-
m
-
m
-
m
-
‐
m
n
-
n
-
n
-
n
-
n
o
p
-
p
p
-
p
-
p
q
r
-
r
-
r
s
-
s
-
s
{
s
-
s
t
-
t
‐
-
t
-
t
-
t
t
-
t
u
v
v
w
x
-
x
y
z
α
β
—
,
δ
π
-

cancer growth

"Microenvironmental influence on microtumour infiltration patterns: 3D-mathematical modelling supported by: In vitro studies" (2018) Luján, E.;Soto, D.;Rosito, M.S. (...)Suárez, C. Integrative Biology (United Kingdom). 10(5):325-334

"Game-changing restraint of Ros-damaged phenylalanine, upon tumor metastasis article" (2018) Gueron, G.;Anselmino, N.;Chiarella, P. (...)Vazquez, E. Cell Death and Disease. 9(2)

"Targeting galectin-1 inhibits pancreatic cancer progression by modulating tumor–stroma crosstalk" (2018) Orozco, C.A.;Martinez-Bosch, N.;Guerrero, P.E. (...)Navarro, P. Proceedings of the National Academy of Sciences of the United States of America. 115(16):E3769-E3778

"R-Spondin3 is associated with basal-progenitor behavior in normal and tumor mammary cells" (2018) Tocci, J.M.;Felcher, C.M.;García Sola, M.E. (...)Kordon, E.C. Cancer Research. 78(16):4497-4511

"Non-myogenic tumors display altered expression of dystrophin (DMD) and a high frequency of genetic alterations" (2017) Luce, L.N.; Abbate, M.; Cotignola, J.; Giliberto, F. Oncotarget. 8(1):145-155

"Human renal adipose tissue induces the invasion and progression of renal cell carcinoma" (2017) Campo-Verde-Arbocco, F.;López-Laur, J.D.;Romeo, L.R. (...)Creydt, V.P. Oncotarget. 8(55):94223-94234

"Reprogramming human A375 amelanotic melanoma cells by catalase overexpression: Upregulation of antioxidant genes correlates with regression of melanoma malignancy and with malignant progression when downregulated" (2016) Bracalente, C.;Ibañez, I.L.;Berenstein, A. (...)Durán, H. Oncotarget. 7(27):41154-41171

"The thyroid status reprograms T cell lymphoma growth and modulates immune cell frequencies" (2016) Sterle, H.A.;Barreiro Arcos, M.L.;Valli, E. (...)Cremaschi, G.A. Journal of Molecular Medicine. 94(4):417-429

"Role of RSUME in inflammation and cancer" (2015) Antico Arciuch, V.G.; Tedesco, L.; Fuertes, M.; Arzt, E. FEBS Letters. 589(22):3330-3335

"Differential effect of heterocyclic d-ribofuranoside derivatives on human prostate cancer cell viability and cell cycle progression" (2014) Gueron, G.;Avanzo, R.E.;Schuster, F. (...)D'Accorso, N.B. Biomedicine and Pharmacotherapy. 68(7):847-854

"Thyroid status modulates T lymphoma growth via cell cycle regulatory proteins and angiogenesis" (2014) Sterle, H.A.;Valli, E.;Cayrol, F. (...)Barreiro Arcos, M.L. Journal of Endocrinology. 222(2):243-255

"Vascular galectins: Regulators of tumor progression and targets for cancer therapy" (2013) Thijssen, V.L.; Rabinovich, G.A.; Griffioen, A.W. Cytokine and Growth Factor Reviews. 24(6):547-558

"Delineating the "galectin signature" of the tumor microenvironment" (2013) Compagno, D.;Laderach, J.D.;Gentilini, L. (...)Rabinovich, A.G. OncoImmunology. 2(4)

"A unique galectin signature in human prostate cancer progression suggests galectin-1 as a key target for treatment of advanced disease" (2013) Laderach, D.J.;Gentilini, L.D.;Giribaldi, L. (...)Rabinovich, G.A. Cancer Research. 73(1):86-96

"Glutathione-S-transferase (GST) polymorphisms are associated with relapse after radical prostatectomy" (2013) Cotignola, J.;Leonardi, D.B.;Shahabi, A. (...)Vazquez, E. Prostate Cancer and Prostatic Diseases. 16(1):28-34

"PI3K/AKT pathway regulates phosphorylation of steroid receptors, hormone independence and tumor differentiation in breast cancer" (2012) Riggio, M.;Polo, M.L.;Blaustein, M. (...)Novaro, V. Carcinogenesis. 33(3):509-518

"Advanced prostate cancer: Reinforcing the strings between inflammation and the metastatic behavior" (2012) Gueron, G.; De Siervi, A.; Vazquez, E. Prostate Cancer and Prostatic Diseases. 15(3):213-221

"The aggressiveness of murine lymphomas selected in vivo by growth rate correlates with galectin-1 expression and response to cyclophosphamide" (2012) Zacarías Fluck, M.F.;Hess, L.;Salatino, M. (...)Scharovsky, O.G. Cancer Immunology, Immunotherapy. 61(4):469-480

"The role of estrogen receptor alpha in breast cancer cell proliferation mediated by progestins " (2012) Lanari, C.;Giulianelli, S.;Vaqué, J.P. (...)Gutkind, J.S. Medicina (Argentina). 72(4):315-320

"Stemness markers characterize IGR-CaP1, a new cell line derived from primary epithelial prostate cancer" (2011) Chauchereau, A.;Al Nakouzi, N.;Gaudin, C. (...)Fizazi, K. Experimental Cell Research. 317(3):262-275

"Key questions in metastasis: New insights in molecular pathways and therapeutic implications" (2011) Gueron, G.; de Siervi, A.; Vazquez, E. Current Pharmaceutical Biotechnology. 12(11):1867-1880

"Fucans, but not fucomannoglucuronans, determine the biological activities of sulfated polysaccharides from laminaria saccharina brown seaweed" (2011) Croci, D.O.;Cumashi, A.;Ushakova, N.A. (...)Nifantiev, N.E. PLoS ONE. 6(2)

"p38γ promotes breast cancer cell motility and metastasis through regulation of RhoC GTPase, cytoskeletal architecture, and a novel leading edge behavior" (2011) Rosenthal, D.T.;Iyer, H.;Escudero, S. (...)Merajver, S.D. Cancer Research. 71(20):6338-6349

"Classical membrane progesterone receptors in murine mammary carcinomas: Agonistic effects of progestins and RU-486 mediating rapid non-genomic effects" (2011) Bottino, M.C.;Cerliani, J.P.;Rojas, P. (...)Lanari, C. Breast Cancer Research and Treatment. 126(3):621-636

"Activation of Stat3 by heregulin/ErbB-2 through the co-option of progesterone receptor signaling drives breast cancer growth" (2009) Proietti, C.J.;Rosemblit, C.;Beguelin, W. (...)Elizalde, P.V. Molecular and Cellular Biology. 29(5):1249-1265

"Critical role of endogenous heme oxygenase 1 as a tuner of the invasive potential of prostate cancer cells" (2009) Gueron, G.;De Siervi, A.;Ferrando, M. (...)Vazquez, E.S. Molecular Cancer Research. 7(11):1745-1755

"Carcinoma-associated fibroblasts activate progesterone receptors and induce hormone independent mammary tumor growth: A role for the FGF-2/FGFR-2 axis" (2008) Giulianelli, S.;Cerliani, J.P.;Lamb, C.A. (...)Lanari, C. International Journal of Cancer. 123(11):2518-2531

"High-risk HPV E6 oncoproteins assemble into large oligomers that allow localization of endogenous species in prototypic HPV-transformed cell lines" (2007) García-Alai, M.M.;Dantur, K.I.;Smal, C. (...)De Prat-Gay, G. Biochemistry. 46(2):341-349

"Nuclear translocation of haeme oxygenase-1 is associated to prostate cancer" (2007) Sacca, P.;Meiss, R.;Casas, G. (...)Vazquez, E. British Journal of Cancer. 97(12):1683-1689

"Oligonucleotide IMT504 induces an immunogenic phenotype and apoptosis in chronic lymphocytic leukemia cells" (2006) Rodrigues, J.M.;Elias, F.;Montaner, A. (...)Dupont, J. Medicina. 66(1):9-16

"Cytogenetic findings, Trp53 mutations, and hormone responsiveness in a medroxyprogesterone acetate induced murine breast cancer model" (2005) Fabris, V.T.;Benavides, F.;Conti, C. (...)Lanari, C. Cancer Genetics and Cytogenetics. 161(2):130-139

"Type I insulin-like growth factor receptor antisense strategies in experimental breast cancer " (2004) Salatino, M.;Schillaci, R.;Proietti, C.J. (...)Elizalde, P.V. Medicina. 64(2):129-134

"Inhibition of in vivo breast cancer growth by antisense oligodeoxynucleptides to type I insulin-like growth factor receptor rnRNA involves inactivation of ErbBs, PI-3K/Akt and p42/p44 MAPK signaling pathways but not modulation of progesterone receptor activity" (2004) Salatino, M.;Schillaci, R.;Proietti, C.J. (...)Elizalde, P.V. Oncogene. 23(30):5161-5174

"p21 modulates threshold of apoptosis induced by DNA-damage and growth factor withdrawal in prostate cancer cells" (2002) Martinez, L.A.;Yang, J.;Vazquez, E.S. (...)Navone, N.M. Carcinogenesis. 23(8):1289-1296

"Actions of immunosuppressor drugs on the development of an experimental ovarian tumor" (2002) Sorianello, E.;Schillaci, R.;Chamson-Reig, A. (...)Libertun, C. Experimental Biology and Medicine. 227(8):658-664

"Involvement of insulin-like growth factors-I and-II and their receptors in medroxyprogesterone acetate-induced growth of mouse mammary adenocarcinomas" (1998) Elizalde, P.V.;Lanari, C.;Molinolo, A.A. (...)Charreau, E.H. Journal of Steroid Biochemistry and Molecular Biology. 67(4):305-317

"Effects of sarcoma 180 growth on interleukin-1 and circulating immune complexes" (1994) Chasseing, N.A.; Eugui, E.M.; Borda, E.S.; Rumi, L. Cancer Investigation. 12(4):390-394

"Studies to determine the possible antitumoral properties of Cobra venom and of Crotoxin Complex A and B" (1988) Baldi, A.;Mordoh, J.;Medrano, E.E. (...)Rumi, L. Medicina. 48(4):337-344

"Cancer and BCG " (1981) Rumi, L.S. Acta Physiologica Latino-Americana. 31(1):25-34